CML Microsystems Director Nathan Zommer Increases Stake with Share Issuance

CML Microsystems director dealing: Nathan Zommer issued 559,134 shares at 262p

CML Microsystems has issued 559,134 new ordinary 5p shares to Non-Executive Director Nathan Zommer at a price of 262 pence per share. Following the issue, Zommer holds 1,251,144 shares, representing approximately 7.54% of CML’s total voting rights.

This is a PDMR dealing disclosure under Article 19 of the EU Market Abuse Regulation, which requires directors and other senior managers to report transactions in their company’s shares.

What “in lieu of cash consideration” means

The RNS states the shares were issued “in lieu of cash consideration,” which simply means the Company chose to settle a payment using equity rather than cash. The RNS does not disclose what the consideration relates to. It could be for fees, services, or another obligation – not disclosed.

At the stated price of £2.62, the issued shares equate to £1,464,931.08. That conserves cash inside the business, though it does modestly dilute existing shareholders. The RNS does not disclose the total shares in issue, so the exact dilution percentage cannot be calculated here.

Why this matters for CML shareholders

Director alignment is the obvious headline. A non-executive director now owns 7.54% of the Company, which is a meaningful stake for an AIM-listed semiconductor business. That can be reassuring: it ties board-level decision-making to shareholder outcomes.

There is, however, a balance. Paying with shares preserves cash – a positive if management see attractive reinvestment opportunities or want to keep the balance sheet robust. On the flip side, issuing new shares increases the share count, which slightly dilutes everyone else. Without the total share count disclosed in this RNS, we can’t quantify the impact.

One thing we cannot deduce from this announcement is whether the 262p issue price was at a discount, premium, or in line with the prevailing market price – not disclosed. So treat any read-across to valuation with care.

Key deal details investors should know

Director	Nathan Zommer (Non-Executive Director)
Number of shares issued	559,134
Issue price	262 pence (£2.62)
Transaction value at stated price	£1,464,931.08
New total holding	1,251,144 shares
Percentage of voting rights	Approximately 7.54%
Nature of transaction	Issue of Ordinary Shares in lieu of cash consideration
Date	8 October 2025
Market	London Stock Exchange, AIM (XLON)
ISIN	GB0001602944
LEI	213800HF8HL7CZDM5C42

My take: a cash-preserving move that tightens alignment

On balance, I’d file this as mildly positive. The Company has opted to preserve cash – always handy in semiconductors, where product cycles and investment needs can be chunky – while a non-exec takes a larger, long-term stake. That combination tends to signal confidence.

The caveat is the dilution. It is real, but unquantified here. If you’re a shareholder, the important lens is whether the cash conserved can earn returns that exceed the long-term cost of issuing equity. If yes, everyone can still come out ahead.

Context: what CML Microsystems does and why it matters

CML develops mixed-signal, RF and microwave semiconductors for global communications markets. It uses a mix of outsourced manufacturing and in-house testing, with trading operations in the UK, Asia and the USA. The strategy focuses on sub-segments within communications with strong growth profiles and high barriers to entry.

The customer base is diverse and blue chip, spanning leading commercial and industrial manufacturers. Management highlights that this breadth helps soften the usual cyclicality in semiconductors.

Growth drivers in CML’s end markets include the push for faster, more secure data transmission, global telecoms infrastructure upgrades, and the rise of private commercial wireless networks tied to the industrial internet of things (IIoT). The Group is cash-generative, has no debt and pays a dividend – a supportive backdrop for a cash-preserving share-based settlement like this.

How to think about director dealings like this

• Alignment: Larger insider stakes tend to align incentives with ordinary shareholders.
• Signalling: Taking shares instead of cash can signal confidence, but the RNS does not say if the director initiated this or accepted it as part of a pre-agreed arrangement.
• Dilution: New shares dilute existing holders. The size of the impact here is not disclosed.
• Valuation context: Without the market price at the time, we can’t assess any discount or premium to 262p.

What to watch next

• Further disclosures: The Company referenced an announcement on 7 October 2025. Any follow-up detail on the underlying consideration could clarify the rationale.
• Share register dynamics: With Zommer at 7.54%, the director is a significant holder. Changes around this level are usually disclosed promptly.
• Capital allocation: If cash has been conserved, look for how it’s deployed – R&D, customer programmes, or returns to shareholders. The RNS itself does not state plans.

Bottom line for retail investors

This is a straightforward director dealing: 559,134 shares issued at £2.62, lifting a non-exec’s stake to 7.54%. It preserves cash, tightens alignment and brings modest dilution. The RNS does not disclose the purpose of the consideration or the company’s total shares in issue, so keep conclusions measured.

If you believe CML’s niche RF and mixed-signal positioning, strong customer mix, and cash-generative, debt-free profile can compound over time, an insider taking more equity can be read as a constructive signal. Just remember the unknowns: dilution quantum and how £1.46 million of cash foregone will translate into future returns.